Ilan Ganot - 13 Feb 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director
Issuer ticker: SLDB
Reported as of: 13 Feb 2026
Net transaction value: -$15,478
SEC form: 4
Accepted by SEC: 18 Feb 2026, 21:32:55 UTC
Prior SEC filing: 06 Feb 2026
Next SEC filing: 11 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot

Key filing fact

Ilan Ganot filed Form 4 for Solid Biosciences Inc. (SLDB) on 18 Feb 2026.

Key facts

This page summarizes Ilan Ganot's Form 4 filing for Solid Biosciences Inc. (SLDB).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Feb 2026, 21:32.

Change

Previous filing in this sequence was filed on 06 Feb 2026.
Current net transaction value: -$15,478.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001727460 Primary reporting owner

Ganot Ilan

Relationship: Director
Address: C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN
Signature: /s/ David Tyronne Howton as attorney-in-fact for Ilan Ganot
Signature date: 18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLDB transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,861
Change %: +19%
Price
Shares after: 30,132
Date: 13 Feb 2026
Ownership: Wife
Footnotes: F1

SLDB transaction

Common Stock

Sale

Transaction value: $15,478
Shares: -2,658
Change %: -8.8%
Price: $5.82
Shares after: 27,474
Date: 18 Feb 2026
Ownership: Wife
Footnotes: F3, F4

SLDB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 99,297
Date: 13 Feb 2026
Ownership: Direct
Footnotes: F2

SLDB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,394
Date: 13 Feb 2026
Ownership: See Footnote
Footnotes: F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -4,861
Change %: -33%
Price: $0.000000
Shares after: 9,722
Date: 13 Feb 2026
Ownership: Wife
Underlying class: Common Stock
Underlying amount: 4,861
Exercise price
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

Footnote F3

This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.23 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.

Footnote F5

Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

Footnote F6

On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.